Keynote: Evolving the promise of precision medicine with theranostics
Join leadership from GE HealthCare to discuss how advances in more precise diagnostics and therapies are evolving to deliver theranostics. Theranostics can help to address today’s challenges in oncology, providing a pathway to hope. Although for some, theranostics is a new service line, it is rapidly expanding, showcasing the need to improve access into routine clinical use. Our Total MI for Theranostics is one step forward to achieving this vision.
Ben Newton, General Manager, Oncology, GE HealthCare
Jamie McCoy, General Manager, Theranostics, GE HealthCare
Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE HealthCare.
Erez Levy - Executive Director – General Manager, Molecular Imaging, GE HealthCare